Healthcare
Live Price
Offline$2.95
+1.37% today
1Y Change
-22.81%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Universe Pharmaceuticals Inc. (UPC) is a Healthcare stock with listed on NASDAQ. The stock last traded around $2.95 and down 22.8% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -22.4%, EPS growth of +26.5%, a dividend yield of 0.0%. What stands out right now is revenue -22.4%, EPS +26.5%, free cash flow +45.3% with operating margin -16.3% and ROIC -4.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UPC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UPC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UPC Max Drawdown
-76.25%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UPC and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.